Receptors expressions on peripheral lymphocytes and CD4+CD183+ as a diagnostics biomarker for rheumatoid arthritis: A case –control study in Ghana

ConclusionCD4+CD183+ best predict RA and is positively correlated with disease activity. CD4+CD183+ could serve as diagnostics and disease-monitoring biomarker for RA; however, it demonstrates low specificity. Future studies should be directed on CD4+CD183+ and other biomarkers to augment their diagnostics performances and routine management in RA.

Source: Immunity, Inflammation and Disease - August 29, 2023 Category: Allergy & Immunology Authors: Samuel Asamoah Sakyi, Tonnies Abeku Buckman, Kwame Yeboah ‐Mensah, Ebenezer Senu, Alfred Effah, Daniel Antwi‐Berko, Dzifa Dey, Maxwell H. Antwi, Joseph Yorke, Andy O. Boateng, Akwasi M. Addei, Muniru M. Tanko, Richard Boateng Tags: ORIGINAL ARTICLE Source Type: research